Genflow Biosciences Plc (LON: GENF) has appointed Gad Berdugo as Independent Non-Executive Chairman, a move intended to support the group’s next phase of corporate development and R&D expansion.
Genflow Biosciences PLC (LON: GENF) A Review of an Exciting 2025
Genflow Biosciences PLC (LON: GENF) said it made solid operational progress during 2025, advancing multiple programmes across aging, metabolic disease and gene therapy, while laying the groundwork for a more
Genflow Biosciences Plc (LON: GENF) Completion of Dosing Phase of Canine Gene Therapy
Genflow Completes Dosing Phase of Canine Gene Therapy Trial No Adverse Events Reported During Administration
Genflow Biosciences Plc (LON: GENF) to pitch longevity gene therapy at JPM 2026
Genflow to Attend the 44th Annual J.P. Morgan Healthcare Conference
Genflow Biosciences Shares Jump 25% on Positive Dog Aging Gene Therapy Results
Update on Animal Health Program
Genflow Biosciences (LON: GENF) Shares Jump 100% After Alternative Share Placement
Genflow Biosciences Raises £440,000 Through Alternative Share Placement.
Genflow Biosciences (LON: GENF) Files Patent Examination Request in China for SIRT6 Variants in NASH
Genflow Biosciences PLC (LON: GENF) has submitted a formal request for examination of its patent application in China relating to proprietary SIRT6 variants designed for the treatment of Non-Alcoholic Steatohepatitis
Genflow Biosciences Advances Toward Human Trials for Ageing Therapies
Genflow Biosciences PLC (LSE: GENF, OTCQB: GENFF) has announced progress across its two core research programmes, bringing it closer to initiating human trials for its gene therapies targeting age-related diseases.
Genflow Biosciences (LON:GENF) Advancements in SIRT6 Variant Patent Application
Genflow Biosciences Advances SIRT6 Variant Patent Application Following Positive Search Report from European Patent Office
Trader’s Café With Zak Mir: The Week In Small Caps, Sunday 7th April 2024
New IPOs This Week: Energy Green Transition / Helix Exploration
Traders Cafe with Zak Mir: Bulletin Board Heroes, Tuesday 29th August 2023
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, Allergy Therapeutics, Amala
Traders Cafe with Zak Mir: Bulletin Board Heroes, Thursday 29th June 2023
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, Amte Power, Belluscura, Cloudbreak